Andrej Segec is originally from Slovakia and a pharmacist by training (Comenius University, Bratislava, Slovakia) with an MSc in Epidemiology (London School of Hygiene and Tropical Medicine, London, UK). He has worked for the European Medicines Agency (EMA) since 2008, in pharmacovigilance, signal detection and signal management, as committee manager for the Pharmacovigilance Risk Assessment Committee (PRAC) and as risk management specialist for anti-infective therapies and vaccines during the COVID-19 pandemic.
Andrej’s current focus is on the generation and use of real world evidence in regulatory decision making and the establishment of the Data Analysis and Real World Interrogation Network (DARWIN EU®).